Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
index medicus (11) 11
oncology (11) 11
transplantation (10) 10
hematology (8) 8
male (8) 8
child (7) 7
infant (7) 7
adolescent (6) 6
child, preschool (6) 6
pediatrics (6) 6
female (5) 5
adult (4) 4
article (4) 4
bone marrow transplantation (4) 4
children (4) 4
immunotherapy (4) 4
natural killer cells (4) 4
severe combined immunodeficiency (4) 4
stem-cell transplantation (4) 4
therapy (4) 4
transplants & implants (4) 4
abridged index medicus (3) 3
animals (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
bone-marrow-transplantation (3) 3
cancer (3) 3
chemotherapy (3) 3
disease (3) 3
hemopoiesis (3) 3
immunology (3) 3
infant, newborn (3) 3
mice (3) 3
neuroblastoma - drug therapy (3) 3
neuroblastoma - mortality (3) 3
stem cells (3) 3
100 (2) 2
allergy (2) 2
bone marrow (2) 2
combined modality therapy (2) 2
complications (2) 2
experience (2) 2
expression (2) 2
genotype (2) 2
genotype & phenotype (2) 2
graft vs host disease - etiology (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hematopoietic stem cells (2) 2
high-risk neuroblastoma (2) 2
interleukin-2 - therapeutic use (2) 2
killer cells, natural - immunology (2) 2
kir (2) 2
ligands (2) 2
malignancy (2) 2
neoplasms - immunology (2) 2
neoplasms - therapy (2) 2
neuroblastoma (2) 2
nk cells (2) 2
patients (2) 2
prognosis (2) 2
radiation (2) 2
risk (2) 2
risk factors (2) 2
survival (2) 2
targeted interleukin-2 therapy (2) 2
tissue donors (2) 2
transplantation, autologous (2) 2
treatment outcome (2) 2
3-iodobenzylguanidine - administration & dosage (1) 1
3-iodobenzylguanidine - adverse effects (1) 1
3-iodobenzylguanidine - therapeutic use (1) 1
3t3 cells (1) 1
acid phosphatase - analysis (1) 1
acute lymphoblastic-leukemia (1) 1
acute myelogenous leukemia (1) 1
acute myeloid-leukemia (1) 1
adoptive transfer (1) 1
alkylation (1) 1
allergic reaction (1) 1
allogeneic bone marrow transplantation (1) 1
allogeneic hematopoietic cell transplantation (1) 1
allogeneic hematopoietic stem cell transplantation (1) 1
alloreactivity (1) 1
amantadine - pharmacology (1) 1
aml trials (1) 1
ammonium chloride - pharmacology (1) 1
anakinra (1) 1
anemia, hemolytic - blood (1) 1
anemia, hemolytic - diagnosis (1) 1
anemia, hemolytic - etiology (1) 1
anti-gd2 antibody (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - analysis (1) 1
antibodies, monoclonal - blood (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal - metabolism (1) 1
antibodies, neoplasm - analysis (1) 1
antibodies, neoplasm - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
by Suzanne Shusterman and Wendy B. London and Stephen D. Gillies and Jacquelyn A. Hank and Stephan D. Voss and Robert C. Seeger and C. Patrick Reynolds and Jennifer Kimball and Mark R. Albertini and Barrett Wagner and Jacek Gan and Jens Eickhoff and Kenneth B. DeSantes and Susan L. Cohn and Toby Hecht and Brian Gadbaw and Ralph A. Reisfeld and John M. Maris and Paul M. Sondel
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 33, pp. 4969 - 4975
Purpose The hu14.18-IL2 fusion protein consists of interleukin-2 molecularly linked to a humanized monoclonal antibody that recognizes the GD2... 
COLONY-STIMULATING FACTOR | STAGE-IV NEUROBLASTOMA | REFRACTORY NEUROBLASTOMA | ONCOLOGY | BONE-MARROW-TRANSPLANTATION | CELLULAR CYTOTOXICITY | TARGETED INTERLEUKIN-2 THERAPY | PLUS INTERLEUKIN-2 | HIGH-RISK NEUROBLASTOMA | CANCER GROUP | MONOCLONAL-ANTIBODY CH14.18 | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Interleukin-2 - adverse effects | Humans | Receptors, Interleukin-2 - blood | Antibodies, Monoclonal - adverse effects | Interleukin-2 - therapeutic use | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Infant | Antineoplastic Agents - therapeutic use | Neuroblastoma - mortality | Antibodies, Monoclonal - blood | Interleukin-2 - immunology | Neuroblastoma - drug therapy | Adolescent | Lymphocyte Count | Adult | Child | Antibodies, Monoclonal - immunology | Interleukin-2 - blood | Index Medicus | Pedi10 | Original Reports | To6 | To23
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Donor selection for ex vivo-expanded natural killer cells as adoptive cancer immunotherapy
by Wang, Wei and Erbe, Amy K and DeSantes, Kenneth B and Sondel, Paul M
Future oncology (London, England), 05/2017, Volume 13, Issue 12, p. 1043
Journal Article
Details down arrow
3. Full Text Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy
by Delgado, David C and Hank, Jacquelyn A and Kolesar, Jill and Lorentzen, David and Gan, Jacek and Seo, Songwon and Kim, KyungMann and Shusterman, Suzanne and Gillies, Stephen D and Reisfeld, Ralph A and Yang, Richard and Gadbaw, Brian and DeSantes, Kenneth B and London, Wendy B and Seeger, Robert C and Maris, John M and Sondel, Paul M
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 23, pp. 9554 - 9561
Response to immunocytokine (IC) therapy is dependent on natural killer cells in murine neuroblastoma (NBL) models. Furthermore, killer immunoglobulin-like... 
POLYMORPHISMS | ONCOLOGY | RITUXIMAB | HLA GENOTYPES | BONE-MARROW | METASTASES | LYMPHOMA | TARGETED INTERLEUKIN-2 THERAPY | ANTI-GD2 ANTIBODY | CANCER | TRANSPLANTATION | Receptors, KIR - genetics | Humans | Neuroblastoma - genetics | Interleukin-2 - therapeutic use | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Genotype | Infant | Treatment Outcome | HLA Antigens - genetics | Polymorphism, Genetic | Young Adult | Receptors, IgG - genetics | Neuroblastoma - drug therapy | Adolescent | Ligands | HLA-C Antigens - genetics | Killer Cells, Natural - metabolism | Child | HLA-B Antigens - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation
by Kim, Miriam and Rao, Seema and Eickhoff, Jens C and Desantes, Kenneth B and Capitini, Christian M
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 2019, p. 1
Hepatic sinusoidal obstruction syndrome (SOS) remains a serious complication of hematopoietic stem cell transplantation (HSCT). In this single institution... 
venoocclusive disease | BMT | antithrombin III | sinusoidal obstruction syndrome | stem cell transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
by Haddad, Elie and Logan, Brent R and Griffith, Linda M and Buckley, Rebecca H and Parrott, Roberta E and Prockop, Susan E and Small, Trudy N and Chaisson, Jessica and Dvorak, Christopher C and Murnane, Megan and Kapoor, Neena and Abdel-Azim, Hisham and Hanson, Imelda C and Martinez, Caridad and Bleesing, Jack J.H and Chandra, Sharat and Smith, Angela R and Cavanaugh, Matthew E and Jyonouchi, Soma and Sullivan, Kathleen E and Burroughs, Lauri and Skoda-Smith, Suzanne and Haight, Ann E and Tumlin, Audrey G and Quigg, Troy C and Taylor, Candace and Dávila Saldaña, Blachy J and Keller, Michael D and Seroogy, Christine M and Desantes, Kenneth B and Petrovic, Aleksandra and Leiding, Jennifer W and Shyr, David C and Decaluwe, Hélène and Teira, Pierre and Gillio, Alfred P and Knutsen, Alan P and Moore, Theodore B and Kletzel, Morris and Craddock, John A and Aquino, Victor and Davis, Jeffrey H and Yu, Lolie C and Cuvelier, Geoffrey D.E and Bednarski, Jeffrey J and Goldman, Frederick D and Kang, Elizabeth M and Shereck, Evan and Porteus, Matthew H and Connelly, James A and Fleisher, Thomas A and Malech, Harry L and Shearer, William T and Szabolcs, Paul and Thakar, Monica S and Vander Lugt, Mark T and Heimall, Jennifer and Yin, Ziyan and Pulsipher, Michael A and Pai, Sung-Yun and Kohn, Donald B and Puck, Jennifer M and Cowan, Morton J and O’Reilly, Richard J and Notarangelo, Luigi D
Blood, ISSN 0006-4971, 10/2018, Volume 132, Issue 17, pp. 1737 - 1749
The Primary Immune Deficiency Treatment Consortium (PIDTC) performed a retrospective analysis of 662 patients with severe combined immunodeficiency (SCID) who... 
CRITERIA | SEVERE COMBINED IMMUNODEFICIENCY | BONE-MARROW-TRANSPLANTATION | DISEASE | HCT | EXPERIENCE | COHORT | STEM-CELL TRANSPLANTATION | HEMATOLOGY | RECONSTITUTION | Plenary Paper | 100
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetes
by McCabe, Kristen E and Pollock, Allison J and Rehm, Jennifer L and DeSantes, Kenneth B
Pediatric Diabetes, ISSN 1399-543X, 12/2017, Volume 18, Issue 8, pp. 832 - 834
The mainstay of treatment for type 1 diabetes (T1D) is exogenous insulin. Here, we report a case in which exogenous insulin requirements were eliminated after... 
aplastic anemia | transplant | type 1 diabetes | autoimmune | BONE-MARROW-TRANSPLANTATION | RISK | REDUCED INTENSITY | MELLITUS | CHILDREN | IMPACT | DISEASES | THERAPY | ENDOCRINOLOGY & METABOLISM | PEDIATRICS | Hematopoietic Stem Cell Transplantation | Male | Diabetes Mellitus, Type 1 - therapy | Humans | Transplantation, Homologous | Adolescent | Transplantation | Type 1 diabetes | Hematopoietic stem cells | Stem cells | Transplants & implants | Diabetes mellitus | Aplastic anemia | Case reports | Diabetes | Insulin | Hemopoiesis | Autoimmune
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Donor selection for ex vivo-expanded natural killer cells as adoptive cancer immunotherapy
by Wang, Wei and Erbe, Amy K and Desantes, Kenneth B and Sondel, Paul M
Future Oncology, ISSN 1479-6694, 05/2017, Volume 13, Issue 12, pp. 1043 - 1047
NK cells | donor selection | KIR-ligands | KIR | immunotherapy | adoptive transfer | ex vivo expansion | INHIBITION | THERAPY | ONCOLOGY | EXPANSION | TRANSPLANTATION
Journal Article
Details down arrow
8. Full Text NK cell-based immunotherapies in pediatric oncology
by McDowell, Kimberly A and Hank, Jacquelyn A and DeSantes, Kenneth B and Capitini, Christian M and Otto, Mario and Sondel, Paul M
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 03/2015, Volume 37, Issue 2, pp. 79 - 93
The past decade has seen several anticancer immunotherapeutic strategies transition from "promising preclinical models" to treatments with proven clinical... 
natural killer cells | neoplasms | immunotherapy | child | NATURAL-KILLER-CELLS | ACUTE MYELOGENOUS LEUKEMIA | TUMOR-CELLS | ACUTE MYELOID-LEUKEMIA | ONCOLOGY | COMPLEX CLASS-I | REGULATORY T-CELLS | INTERLEUKIN-2 THERAPY | PEDIATRICS | HIGH-RISK NEUROBLASTOMA | EX-VIVO | HEMATOLOGY | C-RECEPTOR POLYMORPHISMS | Neoplasms - therapy | Prognosis | Neoplasms - immunology | Humans | Immunotherapy | Killer Cells, Natural - immunology | Adult | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Immunotherapy in pediatric malignancies: Current status and future perspectives
by Capitini, Christian M and Otto, Mario and Desantes, Kenneth B and Sondel, Paul M
Future Oncology, ISSN 1479-6694, 2014, Volume 10, Issue 9, pp. 1659 - 1678
Novel immune-based therapies are becoming available as additions to, and in some cases as alternatives to, the traditional treatment modalities such as... 
natural killer cells | vaccines | immunotherapy | Toll-like receptors | childhood cancer | chimeric antigen receptors | cytokines | monoclonal antibodies | RECURRENT SOLID TUMORS | PULSED DENDRITIC CELLS | WT1 PEPTIDE VACCINATION | BEVACIZUMAB PLUS IRINOTECAN | CHILDRENS ONCOLOGY GROUP | TUMOR-NECROSIS-FACTOR | ONCOLOGY | PHASE-I TRIAL | CHIMERIC-ANTIGEN-RECEPTOR | ACUTE LYMPHOBLASTIC-LEUKEMIA | STEM-CELL TRANSPLANTATION | Pediatrics | Neoplasms - therapy | Neoplasms - immunology | Cancer Vaccines | Humans | Immunotherapy | Child
Journal Article
Details down arrow
10. Full Text Unrelated Donor Bone Marrow Transplantation for Children With Acute Myeloid Leukemia Beyond First Remission or Refractory to Chemotherapy
by Nancy J. Bunin and Stella M. Davies and Richard Aplenc and Bruce M. Camitta and Kenneth B. DeSantes and Rakesh K. Goyal and Neena Kapoor and Nancy A. Kernan and Joseph Rosenthal and Franklin O. Smith and Mary Eapen
Journal of Clinical Oncology, ISSN 0732-183X, 09/2008, Volume 26, Issue 26, pp. 4326 - 4332
Purpose Identify prognostic factors that influence outcome after unrelated donor bone marrow transplantation in children with acute myeloid leukemia (AML).... 
CANCER-GROUP | SURVIVAL | MULTICENTER | THERAPY | ONCOLOGY | AML TRIALS | PEDIATRIC-PATIENTS | VERSUS-HOST-DISEASE | BLOOD | Prognosis | Humans | Risk Factors | Proportional Hazards Models | Child, Preschool | Male | Antineoplastic Agents - therapeutic use | Remission Induction | Leukemia, Myeloid, Acute - mortality | Adolescent | Bone Marrow Transplantation | Female | Tissue Donors | Child | Leukemia, Myeloid, Acute - therapy | Pediatric Oncology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text KIR receptor‐ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells
by Delgado, David and Webster, Daniel E and DeSantes, Kenneth B and Durkin, Emily T and Shaaban, Aimen F
Pediatric Blood & Cancer, ISSN 1545-5009, 12/2010, Volume 55, Issue 7, pp. 1300 - 1305
Background The effectiveness of killer immunoglobulin‐like receptor (KIR) incompatible, alloreactive natural killer (NK) cells has been primarily documented in... 
NK cells | KIR | osteosarcoma | immunotherapy | Osteosarcoma | Immunotherapy | ALLOREACTIVITY | RECOGNITION | DOWN-REGULATION | INHIBITORY RECEPTORS | TUMORS | TRANSPLANTATION | MOLECULES | MHC CLASS-I | MELANOMA | ONCOLOGY | PEDIATRICS | HEMATOLOGY | EXPRESSION | Cytotoxicity Tests, Immunologic | Humans | Histocompatibility Antigens Class I - immunology | Bone Neoplasms - immunology | Reverse Transcriptase Polymerase Chain Reaction | Bone Neoplasms - metabolism | Histocompatibility Antigens Class I - metabolism | Osteosarcoma - immunology | Flow Cytometry | Receptors, KIR - metabolism | Cell Line, Tumor | Killer Cells, Natural - immunology | Major Histocompatibility Complex - immunology | Histocompatibility | Receptors, KIR - immunology | Osteosarcoma - metabolism | Cytotoxicity, Immunologic | Cell culture | Flow cytometry | Pediatrics | Effector cells | Data processing | Immunoglobulin-like receptors | Malignancy | Osteosarcoma cells | Cell surface | Major histocompatibility complex | Donors | Killer cell immunoglobulin-like receptors | Peripheral blood mononuclear cells | Natural killer cells | Solid tumors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc gamma Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
by Delgado, David C and Hank, Jacquelyn A and Kolesar, Jill and Lorentzen, David and Gan, Jacek and Seo, Songwon and Kim, KyungMann and Shusterman, Suzanne and Gillies, Stephen D and Reisfeld, Ralph A and Yang, Richard and Gadbaw, Brian and DeSantes, Kenneth B and London, Wendy B and Seeger, Robert C and Maris, John M and Sondel, Paul M
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 23, pp. 9554 - 9561
Response to immunocytokine (IC) therapy is dependent on natural killer cells in murine neuroblastoma (NBL) models. Furthermore, killer immunoglobulin-like... 
Journal Article
Details down arrow
13. Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
by Shusterman, Suzanne and London, Wendy B and Gillies, Stephen D and Hank, Jacquelyn A and Voss, Stephan D and Seeger, Robert C and Reynolds, CPatrick and Kimball, Jennifer and Albertini, Mark R and Wagner, Barrett and Gan, Jacek and Eickhoff, Jens and DeSantes, Kenneth B and Cohn, Susan L and Hecht, Toby and Gadbaw, Brian and Reisfeld, Ralph A and Maris, John M and Sondel, Paul M
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 33, pp. 4969 - 4975
PURPOSE: The hu14.18-IL2 fusion protein consists of interleukin-2 molecularly linked to a humanized monoclonal antibody that recognizes the GD2... 
Journal Article
Details down arrow
14. Full Text Successful treatment of an infant with constitutional chromosomal abnormality and hemangiopericytoma with chemotherapy alone
by Kate Gowans, L and Bentz, Michael L and Desantes, Kenneth B and Thompson, Kate J
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 06/2007, Volume 29, Issue 6, pp. 409 - 411
Hemangiopericytoma is a rare vascular tumor, of which 5% to 10% occur in the pediatric population. Although usually benign in infants, local recurrence,... 
Infant | Chemotherapy | Hemangiopericytoma | Constitutional chromosomal abnormality | MANAGEMENT | ONCOLOGY | hemangiopericytoma | constitutional chromosomal abnormality | MALIGNANT HEMANGIOPERICYTOMA | PEDIATRICS | infant | HEMATOLOGY | chemotherapy | CHILDREN | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Diagnostic Errors | Humans | Karyotyping | Chromosome Aberrations | Male | Treatment Outcome | Hemangiopericytoma - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)
by Dvorak, Christopher C and Haddad, Elie and Buckley, Rebecca H and Cowan, Morton J and Logan, Brent and Griffith, Linda M and Kohn, Donald B and Pai, Sung-Yun and Notarangelo, Luigi and Shearer, William and Prockop, Susan and Kapoor, Neena and Heimall, Jennifer and Chaudhury, Sonali and Shyr, David and Chandra, Sharat and Cuvelier, Geoff and Moore, Theodore and Shenoy, Shalini and Goldman, Fred and Smith, Angela R and Sunkersett, Gauri and Vander Lugt, Mark and Caywood, Emi and Quigg, Troy and Torgerson, Troy and Chandrakasan, Shanmuganathan and Craddock, John and Dávila Saldaña, Blachy J and Gillio, Alfred and Shereck, Evan and Aquino, Victor and DeSantes, Kenneth and Knutsen, Alan and Thakar, Monica and Yu, Lolie and Puck, Jennifer M
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 01/2019, Volume 143, Issue 1, pp. 405 - 407
To the Editor: There has been increased appreciation in recent years that severe combined immunodeficiency (SCID) is not one disease, but rather a collection... 
ALLERGY | IMMUNOLOGY | Neonates | Severe combined immunodeficiency | Transplants & implants | Radiation | Disorders | Clinical trials | Transplantation | Infants | Lymphocytes T | Alkylation | Defects | Consortia | T-cell receptor | Genotype & phenotype | Killer cells | Newborn babies | Lymphocytes | Diagnosis | Natural killer cells | Genotypes | Autografts | Phenotypes | Cell survival | Complications | Immune reconstitution | Medical screening | Patients | Hemopoiesis | Screening | Chemotherapy | Lymphocytes B | Mutation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study
by Heimall, Jennifer and Logan, Brent R and Cowan, Morton J and Notarangelo, Luigi D and Griffith, Linda M and Puck, Jennifer M and Kohn, Donald B and Pulsipher, Michael A and Parikh, Suhag and Martinez, Caridad and Kapoor, Neena and O'Reilly, Richard and Boyer, Michael and Pai, Sung-Yun and Goldman, Frederick and Burroughs, Lauri and Chandra, Sharat and Kletzel, Morris and Thakar, Monica and Connelly, James and Cuvelier, Geoff and Saldana, Blachy J. Davila and Shereck, Evan and Knutsen, Alan and Sullivan, Kathleen E and Desantes, Kenneth and Gillio, Alfred and Haddad, Elie and Petrovic, Aleksandra and Quigg, Troy and Smith, Angela R and Stenger, Elizabeth and Yin, Ziyan and Shearer, William T and Fleisher, Thomas and Buckley, Rebecca H and Dvorak, Christopher C
Blood, ISSN 0006-4971, 12/2017, Volume 130, Issue 25, pp. 2718 - 2727
The Primary Immune Deficiency Treatment Consortium (PIDTC) is enrolling children with severe combined immunodeficiency (SCID) to a prospective natural history... 
SEVERE COMBINED IMMUNODEFICIENCY | OMENN-SYNDROME | HEMATOLOGY | DEFICIENCY | DISEASE | CHILDREN | Prospective Studies | Humans | Risk Factors | Severe Combined Immunodeficiency - mortality | Child, Preschool | Severe Combined Immunodeficiency - therapy | Genotype | Infant | Male | Neonatal Screening | Infection - etiology | Severe Combined Immunodeficiency - complications | Graft vs Host Disease - drug therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Female | Immune Reconstitution - genetics | Hematopoietic Stem Cell Transplantation - methods | Tissue Donors | Graft vs Host Disease - etiology | Infant, Newborn | 100 | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 study
by Braunstein, Steve E and London, Wendy B and Kreissman, Susan G and Villablanca, Judith G and Davidoff, Andrew M and DeSantes, Kenneth and Castleberry, Robert P and Murray, Kevin and Diller, Lisa and Matthay, Katherine and Cohn, Susan L and Shulkin, Barry and Allmen, Daniel and Parisi, Marguerite T and Ryn, Collin and Park, Julie R and Quaglia, Michael P and Haas‐Kogan, Daphne A
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2019, Volume 66, Issue 7, pp. e27736 - n/a
Purpose Neuroblastoma is the most common extracranial solid pediatric malignancy, with poor outcomes in high‐risk disease. Standard treatment approaches employ... 
neuroblastoma | radiotherapy | lymph nodes | high risk | RESECTION | CHEMOTHERAPY | CHILDREN | LOW-DOSE RADIOTHERAPY | THERAPY | ONCOLOGY | PEDIATRICS | LOCAL-CONTROL | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Stem cells | Radiation | Medical care | Transplantation | Neuroblastoma | Radiotherapy | Quality management | Lymphatic system | Medical treatment | Regional analysis | Health risks | Risk | Malignancy | Radiation therapy | Survival | Patients | Nodes | Lymph nodes | Rank tests | Surgery | Irradiation | Lymph
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT
by Marsh, Rebecca A and Leiding, Jennifer W and Logan, Brent R and Griffith, Linda M and Arnold, Danielle E and Haddad, Elie and Falcone, E Liana and Yin, Ziyan and Patel, Kadam and Arbuckle, Erin and Bleesing, Jack J and Sullivan, Kathleen E and Heimall, Jennifer and Burroughs, Lauri M and Skoda-Smith, Suzanne and Chandrakasan, Shanmuganathan and Yu, Lolie C and Oshrine, Benjamin R and Cuvelier, Geoffrey D. E and Thakar, Monica S and Chen, Karin and Teira, Pierre and Shenoy, Shalini and Phelan, Rachel and Forbes, Lisa R and Chellapandian, Deepak and Dávila Saldaña, Blachy J and Shah, Ami J and Weinacht, Katja G and Joshi, Avni and Boulad, Farid and Quigg, Troy C and Dvorak, Christopher C and Grossman, Debi and Torgerson, Troy and Graham, Pamela and Prasad, Vinod and Knutsen, Alan and Chong, Hey and Miller, Holly and de la Morena, M Teresa and DeSantes, Kenneth and Cowan, Morton J and Notarangelo, Luigi D and Kohn, Donald B and Stenger, Elizabeth and Pai, Sung-Yun and Routes, John M and Puck, Jennifer M and Kapoor, Neena and Pulsipher, Michael A and Malech, Harry L and Parikh, Suhag and Kang, Elizabeth M and Primary Immune Deficiency and submitted on behalf of the Primary Immune Deficiency Treatment Consortium
Journal of Clinical Immunology, ISSN 0271-9142, 10/2019, Volume 39, Issue 7, pp. 653 - 667
Inflammatory bowel disease (IBD) affects approximately 1/3 of patients with chronic granulomatous disease (CGD). Comprehensive investigation of the effect of... 
Medical Microbiology | allogeneic bone marrow transplantation | Biomedicine | Immunology | Allogeneic hematopoietic cell transplantation | chronic granulomatous disease | primary immunodeficiency | Infectious Diseases | Internal Medicine | inflammatory bowel disease | allogeneic hematopoietic stem cell transplantation | X-LINKED CARRIERS | ANAKINRA | IMMUNOLOGY | FEATURES | COMPLICATIONS | EXPERIENCE | STEM-CELL TRANSPLANTATION | BLOCKADE | Inflammatory bowel disease | Graft-versus-host reaction | Inflammatory bowel diseases | Chronic granulomatous disease | Transplants & implants | Intestine | Transplantation | Hemopoiesis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights